ATHA
AthiraยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ATHA Profile
Athira Pharma, Inc.
A biopharmaceutical company developing small molecule therapies for neurodegenerative diseases, with a focus on Alzheimer's disease
18706 North Creek Parkway, Suite 104, Bothell, Washington 98011
--
Athira Pharma, Inc., was incorporated as M3 Biotechnology, Inc., in Washington State on March 31, 2011, and re-registered as a joint stock company in Delaware on October 27, 2015. The company is an late-stage clinical biopharmaceutical company that develops small drug molecules to restore neuronal health and stop neurodegeneration. With the company's product candidates, it aims to provide rapid cognitive improvement and change the course of neurological diseases through its novel mechanism of action.
